Your browser doesn't support javascript.
loading
Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers.
Birkbak, N J; Li, Y; Pathania, S; Greene-Colozzi, A; Dreze, M; Bowman-Colin, C; Sztupinszki, Z; Krzystanek, M; Diossy, M; Tung, N; Ryan, P D; Garber, J E; Silver, D P; Iglehart, J D; Wang, Z C; Szuts, D; Szallasi, Z; Richardson, A L.
Affiliation
  • Birkbak NJ; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Li Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Pathania S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Greene-Colozzi A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Dreze M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Bowman-Colin C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Sztupinszki Z; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • Krzystanek M; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • Diossy M; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • Tung N; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
  • Ryan PD; Texas Oncology, The Woodlands, USA.
  • Garber JE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Silver DP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
  • Iglehart JD; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • Wang ZC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • Szuts D; Institute of Enzymolog, Research Center for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.
  • Szallasi Z; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, USA. Electronic address: Zoltan.szallasi@childrens.harvard.edu.
  • Richardson AL; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, USA. Electronic address: aricha58@jhmi.edu.
Ann Oncol ; 29(4): 903-909, 2018 04 01.
Article in En | MEDLINE | ID: mdl-29452344
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / DNA Damage / Platinum Compounds / RecQ Helicases / Triple Negative Breast Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Ann Oncol Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / DNA Damage / Platinum Compounds / RecQ Helicases / Triple Negative Breast Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Ann Oncol Year: 2018 Document type: Article